A detailed history of Geode Capital Management, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 904,069 shares of STTK stock, worth $1.12 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
904,069
Previous 447,738 101.92%
Holding current value
$1.12 Million
Previous $4 Million 12.82%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$3.56 - $11.18 $1.62 Million - $5.1 Million
456,331 Added 101.92%
904,069 $3.49 Million
Q1 2024

May 13, 2024

BUY
$7.37 - $10.09 $569,855 - $780,168
77,321 Added 20.87%
447,738 $4 Million
Q4 2023

Feb 13, 2024

BUY
$1.37 - $7.24 $37,647 - $198,955
27,480 Added 8.01%
370,417 $2.64 Million
Q3 2023

Nov 13, 2023

BUY
$1.42 - $3.16 $21,505 - $47,858
15,145 Added 4.62%
342,937 $521,000
Q2 2023

Aug 11, 2023

SELL
$2.52 - $3.66 $46,350 - $67,318
-18,393 Reduced 5.31%
327,792 $1.02 Million
Q4 2022

Feb 13, 2023

BUY
$1.96 - $3.26 $30,389 - $50,546
15,505 Added 4.69%
346,185 $796,000
Q3 2022

Nov 14, 2022

BUY
$2.6 - $5.52 $161,519 - $342,918
62,123 Added 23.13%
330,680 $892,000
Q2 2022

Aug 12, 2022

SELL
$2.7 - $4.59 $511,755 - $869,984
-189,539 Reduced 41.38%
268,557 $1.09 Million
Q1 2022

May 13, 2022

BUY
$4.22 - $8.89 $33,367 - $70,293
7,907 Added 1.76%
458,096 $1.95 Million
Q4 2021

Feb 11, 2022

BUY
$8.36 - $21.08 $156,716 - $395,165
18,746 Added 4.34%
450,189 $3.83 Million
Q3 2021

Nov 12, 2021

BUY
$17.57 - $28.95 $1.19 Million - $1.97 Million
67,931 Added 18.69%
431,443 $8.79 Million
Q2 2021

Aug 13, 2021

BUY
$24.14 - $37.68 $2.89 Million - $4.51 Million
119,722 Added 49.11%
363,512 $10.5 Million
Q1 2021

May 12, 2021

BUY
$27.92 - $52.5 $77,282 - $145,320
2,768 Added 1.15%
243,790 $7.13 Million
Q4 2020

Feb 12, 2021

BUY
$19.0 - $57.61 $4.58 Million - $13.9 Million
241,022 New
241,022 $12.6 Million

Others Institutions Holding STTK

About Shattuck Labs, Inc.


  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $52.6M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.